REQUEST A DEMO
Total
USD $0.00
Search more companies

I.P.S. Centro de Salud Ucata - Charta Santander (Colombia)

Main Activities: Hospitals
Full name: I.P.S. Centro de Salud Ucata - Charta Santander Profile Updated: September 03, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

I.P.S. Centro de Salud Ucata - Charta Santander is an enterprise located in Colombia, with the main office in Charta. It operates in the Hospitals industry. It was incorporated on December 18, 2014. In its most recent financial highlights, the company reported a net sales revenue increase of 84.42% in Q12026. Its total assets grew by 10.5% over the same period. The net profit margin of I.P.S. Centro de Salud Ucata - Charta Santander increased by 105.68% in 2026.

Headquarters
Carrera 2 2 79
Charta; Santander; Postal Code: 680551

Contact Details: Purchase the I.P.S. Centro de Salud Ucata - Charta Santander report to view the information.

Basic Information
Registered Capital:
Purchase the I.P.S. Centro de Salud Ucata - Charta Santander report to view the information.
Financial Auditors:
Purchase the I.P.S. Centro de Salud Ucata - Charta Santander report to view the information.
Incorporation Date:
December 18, 2014
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Treasurer
Company Performance
Financial values in the chart are available after I.P.S. Centro de Salud Ucata - Charta Santander report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
84.42%
Total Operating Revenue
318.5%
Operating Profit
N/A
EBITDA
N/A
Net Profit/Loss for the Period
498.95%
Total Assets
10.5%
Total Equity
73.52%
Operating Profit Margin
N/A
Net Profit Margin
105.68%
Return on Equity (ROE)
34.71%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?